it (GW120918) is an oral bioenhancer that targets multiple drug resistance in tumors. In many cases, the appearance of multidrug resistance in cancer is due to a change in expression of protein inhibitors. As of August 2007 it was not listed on GSK's product pipeline. Development is assumed to have been discontinued. 
